uniQure NV (QURE)
22.69
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 21, 16:00
23.22
+0.53
(+2.34%)
After-Hours: 07:49
uniQure Market Cap : 1.573B for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 1.573B |
| October 20, 2026 | 1.575B |
| October 19, 2026 | 1.539B |
| October 16, 2026 | 1.510B |
| October 15, 2026 | 1.561B |
| October 14, 2026 | 1.454B |
| October 13, 2026 | 1.475B |
| October 12, 2026 | 1.514B |
| October 09, 2026 | 1.566B |
| October 08, 2026 | 1.563B |
| October 07, 2026 | 1.604B |
| October 06, 2026 | 1.599B |
| October 05, 2026 | 1.581B |
| October 02, 2026 | 1.627B |
| October 01, 2026 | 1.620B |
| September 30, 2026 | 1.675B |
| September 29, 2026 | 1.699B |
| September 28, 2026 | 2.712B |
| September 25, 2026 | 2.651B |
| September 24, 2026 | 2.657B |
| September 23, 2026 | 2.965B |
| September 22, 2026 | 3.139B |
| September 21, 2026 | 3.072B |
| September 18, 2026 | 3.051B |
| September 17, 2026 | 3.057B |
| Date | Value |
|---|---|
| September 16, 2026 | 2.946B |
| September 15, 2026 | 2.988B |
| September 14, 2026 | 3.115B |
| September 11, 2026 | 3.086B |
| September 10, 2026 | 3.083B |
| September 09, 2026 | 3.189B |
| September 08, 2026 | 3.167B |
| September 04, 2026 | 3.085B |
| September 03, 2026 | 3.110B |
| September 02, 2026 | 3.205B |
| September 01, 2026 | 3.318B |
| August 31, 2026 | 3.375B |
| August 28, 2026 | 3.378B |
| August 27, 2026 | 3.436B |
| August 26, 2026 | 3.533B |
| August 25, 2026 | 3.540B |
| August 24, 2026 | 3.291B |
| August 21, 2026 | 3.354B |
| August 20, 2026 | 3.390B |
| August 19, 2026 | 3.381B |
| August 18, 2026 | 3.285B |
| August 17, 2026 | 3.326B |
| August 14, 2026 | 3.371B |
| August 13, 2026 | 3.263B |
| August 12, 2026 | 3.129B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kymera Therapeutics, Inc. | 9.324B |
| Moderna, Inc. | 98.08B |
| Abivax SA | 7.462B |
| GRAIL, Inc. | 5.923B |
| Arrowhead Pharmaceuticals, Inc. | 8.304B |
Market Cap Related Metrics
| PS Ratio | 75.90 |
| PEG Ratio | -1.726 |
| Price to Book Value | 4.855 |
| Price | 22.69 |
| Earnings Yield | -17.84% |
| PEGY Ratio | -1.726 |